A study to evaluate the effectiveness and cost-effectiveness of different screening strategies for identifying undiagnosed COPD in China, amongst residents (=40 years) in four cities.

Peking University First Hospital0 sites2,499 target enrollmentSeptember 21, 2018

Overview

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33247005/ protocol (added 30/11/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34556515/ (added 07/10/2021)

Registry

who.int

Start Date

September 21, 2018

End Date

March 31, 2020

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

•Current inclusion criteria as of 28/01/2020:
•1\. Aged \=40 years
•2\. Residing in the catchment areas of the participating community health centres or their satellite offices
•Previous inclusion criteria as of 30/04/2019:
•1\. Aged \=40 years
•2\. Residing in the catchment areas of the participating community health centres
•Previous inclusion criteria:
•1\. Aged \=40 years
•2\. Residing in the catchment areas of the participating community centres

•1\. Unable to do spirometry (e.g. dementia, lack of teeth or otherwise cannot make a good seal)
•2\. Contraindicated for spirometry (chest infection in the last 3 weeks, coughing up blood in the last month, severe angina, uncontrolled high blood pressure, pneumothorax or history in the last 3 months of tuberculosis, heart attack, detached retina, or surgery on chest/abdomen/brain/ears/eyes
•3\. Currently pregnant/breastfeeding
•4\. Previous adverse reaction to salbutamol